A two-dose dexamethasone suppression test in patients with psychiatric illness

Area of Science:

• Endocrinology
• Psychiatry
• Neuroscience

Background:

• The dexamethasone suppression test (DST) is a widely used diagnostic tool in psychiatry.
• Abnormal DST results have been linked to various psychiatric disorders, including depression, mania, and schizophrenia.
• Understanding the physiological basis and clinical significance of DST abnormalities is crucial for accurate diagnosis and treatment.

Purpose of the Study:

• To investigate the prevalence and characteristics of abnormal dexamethasone suppression in acute psychiatric inpatients.
• To determine if DST abnormalities can differentiate subtypes of depression.
• To discuss the implications of DST findings in the context of other endocrine conditions.

Main Methods:

• A cohort of 34 acute psychiatric inpatients was exposed to a low and high dose dexamethasone regimen.
• Dexamethasone suppression was monitored in the morning and mid-afternoon.
• Abnormal suppression was defined as 'escape from suppression' during these time points.

Main Results:

• Eleven out of 34 inpatients (32.4%) exhibited abnormal dexamethasone suppression.
• This abnormality was observed in patients with primary depression, mania, and acute schizophrenia.
• In primary depression, abnormal DST did not distinguish between 'endogenous' and 'other depressed' subtypes.

Conclusions:

• Abnormal dexamethasone suppression is prevalent in acute psychiatric inpatients across multiple diagnoses.
• DST findings alone are insufficient to differentiate depression subtypes.
• Caution is advised when interpreting DST nonsuppression, especially in patients with potential endocrine disorders like Cushing's syndrome.